U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C21H27NO3S2.ClH
Molecular Weight 442.035
Optical Activity ( + / - )
Defined Stereocenters 0 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of MAZATICOL HYDROCHLORIDE

SMILES

Cl.CN1C2CCC(C)(C)C1CC(C2)OC(=O)C(O)(C3=CC=CS3)C4=CC=CS4

InChI

InChIKey=KOYYWMFYAIFCBI-UHFFFAOYSA-N
InChI=1S/C21H27NO3S2.ClH/c1-20(2)9-8-14-12-15(13-16(20)22(14)3)25-19(23)21(24,17-6-4-10-26-17)18-7-5-11-27-18;/h4-7,10-11,14-16,24H,8-9,12-13H2,1-3H3;1H

HIDE SMILES / InChI

Molecular Formula ClH
Molecular Weight 36.461
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula C21H27NO3S2
Molecular Weight 405.574
Charge 0
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 0 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including, https://www.ncbi.nlm.nih.gov/pubmed/5000167, https://medical.mt-pharma.co.jp/di/file/dc/pnt.htm

Mazaticol is an anti-acetylcholine agent used in Japan for the treatment of Parkinson's syndrome.

Approval Year

Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
PENTONA

Approved Use

Parkinson's syndrome due to psychotropic drug administration
Doses

Doses

DosePopulationAdverse events​
8 mg single, oral
Studied dose
Dose: 8 mg
Route: oral
Route: single
Dose: 8 mg
Sources:
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: M
Food Status: UNKNOWN
Sources:
Other AEs: uditory hallucination, Delirium...
Other AEs:
uditory hallucination (83.3%)
Delirium
Sources:
AEs

AEs

AESignificanceDosePopulation
Delirium
8 mg single, oral
Studied dose
Dose: 8 mg
Route: oral
Route: single
Dose: 8 mg
Sources:
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: M
Food Status: UNKNOWN
Sources:
uditory hallucination 83.3%
8 mg single, oral
Studied dose
Dose: 8 mg
Route: oral
Route: single
Dose: 8 mg
Sources:
healthy, ADULT
Health Status: healthy
Age Group: ADULT
Sex: M
Food Status: UNKNOWN
Sources:
PubMed

PubMed

TitleDatePubMed
Population pharmacokinetics of haloperidol using routine clinical pharmacokinetic data in Japanese patients.
2002
Effects of anticholinergic antiparkinsonian drugs on binding of muscarinic receptor subtypes in rat brain.
1990-09
Computerized EEG study on drug-induced extrapyramidalism in schizophrenic patients.
1982
Metabolic fate of 6,6,9-trimethyl-9-azabicyclo(3,3,1)non-3 -yl , -di(2-thienyl)glycolate hydrochloride monohydrate (PG-501).
1972-08
[Absorption, distribution and excretion of 14 C-labelled 6,6,9-trimethyl-9-azabicyclo(3,3,1)non-3 -yl a,a-di(2-thienyl)glycolate hydrochloride monohydrate (PG-501)].
1972-08
[Pharmacological properties of 6,6,9-trimethyl-9-azabicyclo (3,3,1)non-3 beta-yl-alpha, alpha-di(2-thienyl) glycolate hydrochloride monohydrate (PG-501), a new anti-parkinsonian agent].
1971-07
Pharmacology of a new anti-parkinsonian drug: KAO-264.
1971-04

Sample Use Guides

1 tablet (4 mg) is administered orally three times a day. In case of taking Pentona 1%, 0.4 g should be administered the same way.
Route of Administration: Oral
In Vitro Use Guide
Curator's Comment: the full-text can be found here: https://www.jstage.jst.go.jp/article/fpj1944/67/4/67_4_387/_pdf
Anti-acetylcholine activity of mazaticol on he isolated guinea-pig ileum preparation was studied in vitro. ED50 value was 6.4*10(-9) g/ml.
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:06:12 GMT 2025
Edited
by admin
on Mon Mar 31 20:06:12 GMT 2025
Record UNII
44WQI5180Q
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MAZATICOL HYDROCHLORIDE
JAN   WHO-DD  
Common Name English
PENTONA
Preferred Name English
MAZATICOL HYDROCHLORIDE [JAN]
Common Name English
PG 501
Code English
KAO 264
Code English
Mazaticol hydrochloride [WHO-DD]
Common Name English
PG-501
Code English
2-THIOPHENEACETIC ACID, .ALPHA.-HYDROXY-.ALPHA.-2-THIENYL-, (1R,3R,5R)-6,6,9-TRIMETHYL-9-AZABICYCLO(3.3.1)NON-3-YL ESTER, HYDROCHLORIDE, REL-
Common Name English
KAO-264
Code English
Code System Code Type Description
FDA UNII
44WQI5180Q
Created by admin on Mon Mar 31 20:06:12 GMT 2025 , Edited by admin on Mon Mar 31 20:06:12 GMT 2025
PRIMARY
SMS_ID
100000086161
Created by admin on Mon Mar 31 20:06:12 GMT 2025 , Edited by admin on Mon Mar 31 20:06:12 GMT 2025
PRIMARY
EVMPD
SUB03096MIG
Created by admin on Mon Mar 31 20:06:12 GMT 2025 , Edited by admin on Mon Mar 31 20:06:12 GMT 2025
PRIMARY
CAS
32891-29-5
Created by admin on Mon Mar 31 20:06:12 GMT 2025 , Edited by admin on Mon Mar 31 20:06:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID701350417
Created by admin on Mon Mar 31 20:06:12 GMT 2025 , Edited by admin on Mon Mar 31 20:06:12 GMT 2025
PRIMARY
PUBCHEM
135004
Created by admin on Mon Mar 31 20:06:12 GMT 2025 , Edited by admin on Mon Mar 31 20:06:12 GMT 2025
PRIMARY
ChEMBL
CHEMBL2105187
Created by admin on Mon Mar 31 20:06:12 GMT 2025 , Edited by admin on Mon Mar 31 20:06:12 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
SOLVATE->ANHYDROUS
Related Record Type Details
ACTIVE MOIETY